 |
Patricia K. Scheller
Chief Executive Officer
Ms. Scheller's commitment to the healthcare industry spans more than 20 years. Prior to joining Prescient Medical, she was the CEO of SomaLogic, a molecular diagnostic company dedicated to developing protein signature arrays. Ms. Scheller also managed several business units at Ortho-Clinical Diagnostics and was director of cardiology systems at Cordis, a Johnson & Johnson company renowned for pioneering vascular disease treatments. There, she was responsible for launching the first PALMAZ-SCHATZ® balloon-expandable Stent in the United States. Ms. Scheller also served in key executive positions at Dade Behring, a clinical diagnostics firm.
Education:
Undergraduate
B.S.E., Biomedical Engineering, Duke University
Executive Business Programs
Harvard Business School
MIT Sloan School of Management
Columbia University
Kellogg School of Management at Northwestern University
|
 |
Scott C. Durbin
Chief Financial and Operating Officer
For over 12 years, Mr. Durbin has focused on corporate finance and strategy for the medical device and pharmaceutical industries. Before joining Prescient Medical, he was a corporate development consultant for Scios Inc., Johnson & Johnson's cardiovascular drug subsidiary. He also served as a financial consultant to Alteon Inc., a company focused on the development of novel therapeutics for heart disease. Prior to consulting, Mr. Durbin spent several years as an investment banker with Lehman Brothers, Inc. His tenure there included the successful execution of over $2 billion in financings and merger related advisory transactions for cardiovascular companies in the medical device and biopharmaceutical industries. Mr. Durbin began his career as a Director of Neurophysiology for Biotronic, Inc.
Education:
Undergraduate
B.S., University of Michigan
Graduate
M.P.H. (Health Management), Yale University School of Medicine and School of Management
|
 |
Ilana Odess
General Manager
Ms. Odess has 15 years of healthcare industry experience, with over 10 years in business development and product management, focusing on cardiovascular diseases. Prior to working at Prescient Medical, Ms. Odess was Executive Vice President, Marketing & Sales of Advanced Stent Technologies, Inc., a company that developed bifurcated coronary stents for the treatment of arterial stenosis and restenosis. Ms. Odess successfully executed distribution agreements throughout Asia, Europe, Latin America, Canada, and the Middle East. Previously, Ms. Odess was based in Brussels, Belgium, as Director of Business Development & Marketing EMEA for Cordis Corp., a Johnson & Johnson company. She was responsible for the successful launch of an AAA (Abdominal Aortic Aneurysm) treatment in 24 countries. Ms. Odess has also served as Business Unit Director for Cordis, Israel.
Education:
Undergraduate
B.S., Biochemistry, Bar Ilan University, Israel
Graduate
M.B.A., Bar Ilan University, Israel
|
 |
Michele V. Frank
General Counsel
Ms. Frank serves as our General Counsel. She is currently associated with Patton Boggs LLP, which provides Prescient its legal services. She has worked with early stage medical device companies throughout her legal career, and specializes in the area of intellectual property, including developing and managing intellectual property portfolios.
Education:
Undergraduate
B.S., Mechanical Engineering, Union College
Graduate
J.D., American University Washington College of Law
|
 |
James F. Brennan III, Ph.D.
Chief Science Officer
Dr. Brennan serves as the Executive Vice President of Research & Development. Dr. Brennan is the author of several seminal works concerning the use of Raman spectroscopy for analyzing human coronary artery and is a recognized expert in optical fibers and devices. He has pioneered several technology platforms and built Intellectual Property portfolios protecting them. Prior to joining PMI, he served as the Vice President of Research & Development for Raydiance, Inc. (Orlando, FL) where he designed and commercialized their femtosecond-duration pulsed laser systems for medical, industrial, and defense applications. Prior to that, Dr. Brennan worked with several laboratories and institutions, including 3M Company as a chief scientist where he built their Optical Components program from fledgling acquisitions. He has experience at several additional laboratories including Lincoln Laboratory, Academisch Ziekenhuis (Leiden, Netherlands), and the MIT Harrison Spectroscopy Laboratory. He is the author of and has published over 60 journal and conference papers, four book chapters, and has been granted 18 patents (several patents pending).
Education
Undergraduate
S.B., Massachusetts Institute of Technology
Graduate
S.M. and E.E., Electrical Engineering Massachusetts Institute of Technology
Ph.D., Physics and Electrical Engineering, Massachusetts Institute of Technology
|
 |
Robert Burgermeister
Vice President, Research & Development
Mr. Burgermeister has a demonstrated track record of developing multigenerational balloon expandable stent designs. Prior to joining Prescient Medical in 2007, he spent ten years with Cordis, a Johnson & Johnson company in Warren, NJ, advancing through the Advanced Research and Development group to Engineering Fellow. From 1985 through 1997, Mr. Burgermeister served as a Research and Development Engineer at Kearfott Guidance and Navigation, in Wayne, NJ. He has over 60 patent applications and eight issued patents, and has presented worldwide on the evolution of stent design. Mr. Burgermeister was also responsible for collaborative efforts regarding dynamic coronary vascular motion characterization and in-vitro simulation, leading to discoveries on biological response as a result of device implantation.
Education:
Undergraduate
BEng, Stevens Institute of Technology
|
|